Medical/Pharmaceuticals

Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging

MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has accepted the filing of a New Drug Application (...

2026-01-20 06:15 5813

Sakai Clinic 62 Founder & Medical Director Mari Sakai Holds Dialogue with Peter Nobel, Chairman of the Nobel Sustainability Trust, Declaring Global Leadership as a Pioneer of Medical Sustainability

TOKYO, Jan. 20, 2026 /PRNewswire/ -- Sakai Clinic 62 (Location: Shibuya-ku, Tokyo; Founder & Medical Director: Mari Sakai) announces that Dr. Mari Sakai held a dialogue with Mr. Peter Nobel, Chairman of the Nobel Sustainability Trust (NST), to discuss the international promotion of sustainability...

2026-01-20 00:00 5832

Ageing, smoking, oral bacteria and genetic mutations linked to higher stomach cancer risk

* Duke-NUS and NUHS scientists uncover a complex web of genetic, age-related and microbial factors that increase the risk of stomach cancer. * Age-related blood cell mutations may trigger early changes in the stomach lining, offering new insights into how cancer risk builds over time and unde...

2026-01-19 20:07 7036

D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002

SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications: * D3S‑003 — ...

2026-01-19 09:00 5584

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Biopsy of theProstate Avoidance Stratification Study), a Phase 3 trial ...

2026-01-17 03:21 4964

Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs

SHANGHAI and HONG KONG, Jan. 16, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-01-16 09:00 8820

Kelun-Biotech Showcases Innovative Achievements and Future Development Strategy at the 44th Annual JPM Healthcare Conference

CHENGDU, China, Jan. 16, 2026 /PRNewswire/ -- From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and CEO of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990....

2026-01-16 02:30 12320

MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026

Medical AI Made Easy—From Lab to Real-World Training & Practical Use CHEROKEE, Texas, Jan. 15, 2026 /PRNewswire/ -- MediCapture Inc., a global leader in medical imaging systems, today announced the launch of aiScope™, software that runs Vision AI models in real-time, locally on MediCapture'sMTR ...

2026-01-15 17:00 4811

/C O R R E C T I O N -- Informa Markets/

In the news release, "International Healthcare Week Returns to Thailand in 2026 with Expanded Industry Reach", issued on 15 January 2026 by Informa Markets. over PR Newswire, we are advised by the company that the testimonial featured on behalf of i-SENS, South Korea., the name mentioned should ...

2026-01-15 14:17 6856

Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease

SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for AB...

2026-01-15 12:11 6421

AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products

HONG KONG, Jan. 15, 2026 /PRNewswire/ -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully completed the Phase III clinical site work. This marks th...

2026-01-15 08:30 7390

Heartstream Launched as Independent Emergency Care Company

Former Philips Emergency Care business becomes first platform company of Emergency Care Holdings, advancing a century-long mission to save lives BOTHELL, Wash., Jan. 15, 2026 /PRNewswire/ -- Emergency Care Holdings (ECH), a platform formed by Bridgefield Capital to assemble and grow category-lead...

2026-01-15 00:45 3126

Metabolon Appoints Celia Reyes as Vice President of Human Resources

Celia Reyes will lead Metabolon's global people strategy as the company continues to scale in the evolving multiomics marketplace MORRISVILLE, N.C., Jan. 14, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science resea...

2026-01-14 22:00 3525

NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi Biotech Alliance Summit Begins in SF

NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi ...

2026-01-14 21:55 9733

iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System

ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc ., creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system...

2026-01-14 21:03 3923

Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences

LOS GATOS, Calif., Jan. 14, 2026 /PRNewswire/ -- Lynx Analytics today announced  Lumen , a specialized Agentic AI framework designed to help pharmaceutical and biotech organizations generate strategic, decision-ready insights from c...

2026-01-14 21:00 3862

Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

MELBOURNE, Australia, Jan. 14, 2026 /PRNewswire/ -- Rhythm Biosciences Ltd ('RHY ', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated geneTypeTM Colorectal Cancer (CRC) Risk Asses...

2026-01-14 11:40 3035

DNV SUPPORTS NOUL IN IVDR CERTIFICATION FOR AI-BASED MEDICAL DIAGNOSTIC PRODUCTS

SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer diagnostics company Noul to certify their malaria diagnosis, blood cell morphology and cervical cancer testing solutions, under...

2026-01-14 08:00 7068

Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program

SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- Rakuten Medical, Inc. and LOTTE Biologics today announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P. Morgan Healthcare Conference in San Francisco to strengthen Rakuten Medical's production capabili...

2026-01-14 07:34 6457

ArisGlobal Accelerates Growth and AI Adoption Following Strong 2025 Performance

More than 100 new and expanded LifeSphere customers, 34 global go-lives, and rapid enterprise adoption of NavaX signal strong momentum BOSTON, Jan. 14, 2026 /PRNewswire/ -- ArisGloba

2026-01-13 23:54 2332
1 ... 25262728293031 ... 392